Video
Video
Tardive dyskinesia: Screening and management
Sanjay Gupta, MD, discusses 2 new treatments for tardive dyskinesia.
Conference Coverage
VIDEO: Novel postpartum depression drug effective in phase 3 trial
AUSTIN, TEXAS – Brexanolone, administered intravenously, is under review at the FDA for treating postpartum depression.
Conference Coverage
VIDEO: National suicide hotline could result from pending U.S. law
A bill pending in Congress would assess the feasibility of a national “N11” number for suicide interventions and mental health crises.
Conference Coverage
VIDEO: Eptinezumab shows efficacy in episodic and chronic migraine trials
LOS ANGELES – One-third of patients on a high dose of the novel CGRP-blocking monoclonal antibody saw migraines reduced by 75%.
Conference Coverage
VIDEO: Encouraging results reported for novel Huntington’s disease therapy
LOS ANGELES – In a short, 46-patient trial, the antisense oligonucleotide IONIS-HTTRx safely reduced CSF concentrations of the huntingtin protein...
Conference Coverage
VIDEO: Ubrogepant reduced pain, related symptoms of a migraine attack
Significantly more patients treated with the CGRP blocker saw pain relief within 2 hours of taking the oral medication, compared with placebo.
Conference Coverage
VIDEO: Fix physician burnout? You need more than yoga
Physicians looking to renew their professional satisfaction and personal well-being should turn to an unlikely ally.
Conference Coverage
VIDEO: A treatment plan for medicine’s gender inequities
A new generation of younger physicians - women and men - can reshape medicine's mindset on gender equity.
Video
Depression and substance abuse
Mark S. Gold, MD, discusses whether depression causes substance abuse, or vice versa.
Video
Ketamine for mood disorders?
Gerard Sanacora, PhD, MD, discusses whether it is appropriate to offer ketamine off-label for the treatment of mood disorders.